Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Joy Fridey"'
Autor:
Edward L. Murphy, Baoguang Wang, Ronald A. Sacher, Joy Fridey, James W. Smith, Catharie C. Nass, Bruce Newman, Helen E. Ownby, George Garratty, Sheila T. Hutching, George B. Schreiber
Publikováno v:
Emerging Infectious Diseases, Vol 10, Iss 1, Pp 109-116 (2004)
Human T-lymphotropic virus types I and II (HTLV-I and -II) cause myelopathy; HTLV-I, but not HTLV-II, causes adult T-cell leukemia. Whether HTLV-II is associated with other diseases is unknown. Using survival analysis, we studied medical history data
Externí odkaz:
https://doaj.org/article/1ebc301e135147ef942678f182b9c81a
Autor:
Srijana Rajbhandary, Chester Andrzejewski, Joy Fridey, Brie Stotler, Hamilton C. Tsang, Salwa Hindawi, Opal Reddy, Mayrin Correa Medina, Anna Razatos, Shruthi Narayan, Mark Fung
Publikováno v:
Transfusion. 62:540-545
Under-transfusion is an underreported entity within most hospitals and hemovigilance systems. While critical blood shortages are being reported more frequently, without incident codes to document instances of under-transfusion due to lack of inventor
Autor:
Nancy L Van Buren, Alyssa Ziman, Mary Townsend, Camille M. van Buskirk, Joseph H Cho, Joy Fridey, Maha Al-Ghafry, Beth A. Dy, Rita Reik, James R. Stubbs, Jerome L. Gottschall, Richard R Gammon, Srijana Rajbhandary, George B. Schreiber, Michelle P. Zeller, Mark K. Fung, Hany Kamel
Publikováno v:
Transfusion
Background Although the safety and therapeutic efficacy of COVID‐19 convalescent plasma (CCP) has been extensively evaluated, the safety of CCP donation has not been explored in a multi‐institutional context. Study design and methods Nine blood c
Autor:
Ellen Klapper, Chelsea Hayes, Jamel A. Groves, Joy Fridey, Laura Stephens, Robert E. Snyder, Susan L. Stramer
Publikováno v:
Transfusion. 60:424-429
BACKGROUND Despite West Nile virus (WNV) blood donation screening using nucleic acid testing (NAT), donors with low viral loads not detected by mini-pool-NAT have led to transfusion transmitted (TT)-WNV infection. We describe a probable case of fatal
Autor:
Stephen J. Wagner, Joy Fridey, Steve Miller, Richard J. Benjamin, Emily D. Crawford, Sonia Bakkour, Susan L. Stramer, Michael P. Busch, Ashok Nambiar, Thea Lu, Marion C. Lanteri, Charles Langelier, Jack Kamm, Morvarid Moayeri
Publikováno v:
Transfusion.
Background Strategies to reduce platelet (PLT) bacterial contamination include donor screening, skin disinfection, sample diversion, bacterial culture, pathogen reduction (PR), and day-of-transfusion tests. We report bacterial sepsis following a path
Fatal Sepsis Associated with Bacterial Contamination of Platelets - Utah and California, August 2017
Autor:
Ashok Nambiar, Amy Nichols, Susan L. Stramer, Kelly F. Oakeson, Nicholas Vlachos, Joy Fridey, Wendy Garcia, Bert K. Lopansri, Robert Hunter, Sridhar V. Basavaraju, Walter E. Kelley, Roberta Horth, Janice J. Kim, Sarah J. Ilstrup, Lynn Ramirez-Avila, Jefferson M. Jones, Allyn Nakashima, Gillian McAllister
Publikováno v:
Morbidity and Mortality Weekly Report
During August 2017, two separate clusters of platelet transfusion-associated bacterial sepsis were reported in Utah and California. In Utah, two patients died after platelet transfusions from the same donation. Clostridium perfringens isolates from o
Autor:
Richard Sposto, Kiran Mudambi, Suzy Ghazarossian, Kathleen S. Ruccione, Joy Fridey, David R. Freyer
Publikováno v:
Pediatric Blood & Cancer. 59:697-702
Background Packed red blood cell (PRBC) transfusion is a mainstay in childhood cancer treatment, but has potential for inducing iron overload. The purpose of this study was to determine whether treatment intensity is predictive of projected iron burd
Autor:
Zhanna Kaidarova, Alyssa Ziman, Joan Gibble, James W. Smith, Joy Fridey, Hope H. Biswas, John W. Engstrom, Bruce Newman, Edward L. Murphy, George Garratty, Ronald A. Sacher
Publikováno v:
Neurology. 73:781-789
Background: Human T-lymphotropic virus (HTLV) type I is the causative agent of HTLV-associated myelopathy (HAM)/tropical spastic paraparesis, and a number of HAM cases with HTLV-II infection have also been reported. However, despite some reports, it
Autor:
S Hutching, Bruce Newman, Ronald A. Sacher, Catharie C. Nass, Joy Fridey, Edward L. Murphy, James W. Smith, Baoguang Wang, H.E. Ownby, George B. Schreiber, George Garratty
Publikováno v:
Emerging Infectious Diseases
Emerging infectious diseases, vol 10, iss 1
Murphy, EL; Wang, BG; Sacher, RA; Fridey, J; Smith, JW; Nass, CC; et al.(2004). Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection. EMERGING INFECTIOUS DISEASES, 10(1), 109-116. doi: 10.3201/eid1001.020714. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/2r43g4xd
Emerging Infectious Diseases, Vol 10, Iss 1, Pp 109-116 (2004)
Emerging infectious diseases, vol 10, iss 1
Murphy, EL; Wang, BG; Sacher, RA; Fridey, J; Smith, JW; Nass, CC; et al.(2004). Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection. EMERGING INFECTIOUS DISEASES, 10(1), 109-116. doi: 10.3201/eid1001.020714. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/2r43g4xd
Emerging Infectious Diseases, Vol 10, Iss 1, Pp 109-116 (2004)
Human T-lymphotropic virus types I and II (HTLV-I and -II) cause myelopathy; HTLV-I, but not HTLV-II, causes adult T-cell leukemia. Whether HTLV-II is associated with other diseases is unknown. Using survival analysis, we studied medical history data
Autor:
BG Wang, Joy Fridey, John W. Engstrom, Ronald A. Sacher, James W. Smith, Catharie C. Nass, D. Smith, Kevin R. Loughlin, Edward L. Murphy, B. Newman, Jennie R. Orland, George Garratty
Publikováno v:
Neurology. 61:1588-1594
Background: Almost 20 years after its discovery, the prevalence and clinical course of human T-lymphotropic virus type I (HTLV-I)–associated myelopathy (HAM, also known as tropical spastic paraparesis [TSP]) remain poorly defined. Whereas the causa